SPED Semiannual Convention 2020: Recordings
{{svg_quality_icon}}
{{quality-options}}
Francisco Nieves, MD
1-1 Precocious Puberty: Signaling and Diagnostic Challenges
Francisco Nieves, MD
{{svg_quality_icon}}
{{quality-options}}
Francis P. Baco, MD
2-1 Case Based Continuous Glucose Monitoring Reports and Interpretation
Francis P. Baco, MD
{{svg_quality_icon}}
{{quality-options}}
(Compulsorio JLMPR)
Madeline Gutiérrez, MD
1-2 Prevención, Manejo y Diagnóstico de Diabetes (Compulsorio JLMPR)
(Compulsorio JLMPR)
Madeline Gutiérrez, MD
{{svg_quality_icon}}
{{quality-options}}
Milliette Alvarado, MD
1-3 Prevención Manejo de Obesidad Adulto y Pediátrico (Compulsorio JLMPR)
Milliette Alvarado, MD
{{svg_quality_icon}}
{{quality-options}}
Loida González, MD
1-4 Adrenal fatigue and New therapies in Adrenal Dysfunction
Loida González, MD
{{svg_quality_icon}}
{{quality-options}}
Anand Vaidya, MD
1-5 Martínez de Andino Memorial Lecture: The Evolution of the Primary Aldosteronism Syndrome
Anand Vaidya, MD
{{svg_quality_icon}}
{{quality-options}}
Margarita Ramírez, MD
2-2 Update in Insulin Therapies
Margarita Ramírez, MD
{{svg_quality_icon}}
{{quality-options}}
Jennifer McVean, MD
2-3 Automated Insulin Delivery Systemsfor Persons with Type 1 Diabetes
Jennifer McVean, MD
{{svg_quality_icon}}
{{quality-options}}
Paola Mansilla, MD
2-4 DEBATE: Should we Utilize Diabetes Technology in Persons? YES
Paola Mansilla, MD
{{svg_quality_icon}}
{{quality-options}}
Yaneris Agosto, MD
2-5 DEBATE: Should we Utilize Diabetes Technology in Persons? NO
Yaneris Agosto, MD
{{svg_quality_icon}}
{{quality-options}}
Yaneris Agosto, MD & Paola Mansilla, MD
2-6 DEBATE: Should we Utilize Diabetes Technology in Persons? Rebuttals Conclusion
Yaneris Agosto, MD & Paola Mansilla, MD
{{svg_quality_icon}}
{{quality-options}}
Ariel Zisman, MD
2-7 Use of BeAM and AGP toDetermine the Next Anti-Glycemic Therapy
Ariel Zisman, MD
{{svg_quality_icon}}
{{quality-options}}
José García Mateo, MD
2-8 SGLT2i GLP1a,when and to whom?
José García Mateo, MD